O'Keefe Kenneth W 4
4 · Jazz Pharmaceuticals plc · Filed Aug 6, 2024
Insider Transaction Report
Form 4
O'Keefe Kenneth W
Director
Transactions
- Award
Ordinary Shares
[F1]2024-08-02+3,731→ 28,454 total - Tax Payment
Ordinary Shares
[F2]2024-08-06$111.35/sh−1,484$165,243→ 26,970 total
Holdings
- 4,445(indirect: By Trust)
Ordinary Shares
[F3]
Footnotes (3)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F3]Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
Signature
By: /s/Adam Guttmann, as attorney in fact For: Kenneth O'Keefe|2024-08-06